Why the Industry is Testing the Wrong Thing The life sciences industry faces a growing paradox: organizations are investing heavily in AI, yet many evaluation methods fail to measure how these systems actually perform in real-world evidence synthesis workflows. Every week, new evaluations emerge, and task forces publish guidelines. Academic papers rank AI tools. Organizations…
The Systematic Literature Review Definition: Systematic Literature Review (SLR) is a rigorous, structured, and transparent process of identifying, analyzing, and synthesizing all existing research on a clearly defined question or topic, providing a comprehensive summary and critical evaluation of the evidence. If you’ve ever tried to pull together evidence for a big research question, you’ll…
Today’s Reality vs. Future of Medical Affairs Imagine a seasoned oncologist in her clinic, preparing for morning rounds. Two decades ago, understanding the safety profile of a novel compound often meant waiting for a Medical Science Liaison (MSL) to deliver a curated slide deck. The MSL acted as a highly credible, yet fundamentally transactional, data…
Introduction: The Next Wave of Pharma Innovation In the life sciences, regulatory content has always played a critical role, yet it has rarely been treated as a strategic asset. Documents such as clinical summaries, regulatory submissions, safety reports, and evidence dossiers are essential for compliance, but they are often viewed as static outputs rather than…
